Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2023, 5(11); doi: 10.25236/IJFM.2023.051109.

Medication Adherence and Influencing Factors of Elderly Hypertensive Patients during the COVID-19 Period: A Cross-Sectional Study in Chengdu, China


Li Xiangxi, Chen Jiali, Wu Yan, Yu Zhongjie, Shuai Xiaolong

Corresponding Author:
Shuai Xiaolong

Chengdu University of Traditional Chinese Medicine, Chengdu, China, 611100


To investigate the medication adherence of elderly hypertensive patients in community during the COVID-19 period and analyze its influencing factors. 392 elderly patients with hypertension were selected from two communities in Chengdu, Sichuan Province, and were investigated by demographic characters, circumstances in COVID-19 period, Morisky Medication Adherence Scale. chi-square test and binary logistic regression analysis were performed by SPSS 25.0 software. The medication adherence prevalence of elderly hypertensive patients from two communities in Chengdu was 43.37%. Binary logistic regression analysis showed that marital status, antihypertensive drug use during COVID-19 vaccination, antihypertensive drug use during COVID-19 treatment and emotional situation during the COVID-19 period were independent influencing factors of medication adherence of elderly hypertensive patients. During the COVID-19 period medication adherence among elderly hypertensive patients from two communities in Chengdu was poor.


COVID-19 period; Elderly; Hypertension; Medication adherence; Influencing factors

Cite This Paper

Li Xiangxi, Chen Jiali, Wu Yan, Yu Zhongjie, Shuai Xiaolong. Medication Adherence and Influencing Factors of Elderly Hypertensive Patients during the COVID-19 Period: A Cross-Sectional Study in Chengdu, China. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 11: 55-62. https://doi.org/10.25236/IJFM.2023.051109.


[1] Hypertension. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hypertension. Accessed 2023-07-23.

[2] Organization WH. Global report on hypertension: The race against a silent killer. https://www.who.int/publications/i/item/9789240081062. Accessed 2023-07-23.

[3] Souza AC, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saude Publica. 2016;50:71.

[4] Choudhry NK, Kronish IM, Vongpatanasin W, et al. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022;79(1):e1-e14.

[5] Foster M, Etchin A, Pope C, Hartmann CW, Emidio O, Bosworth HB. The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review. Curr Hypertens Rep. 2023.

[6] Gómez-Escalonilla Lorenzo S, Martínez I, Notario Pacheco B. Influence of COVID-19 on treatment adherence and psychological well-being in a sample of hypertensive patients: a cross-sectional study. BMC Psychiatry. 2023;23(1):121.

[7] WHO downgrades COVID-19 global threat level. China Daily. https://www.chinadaily.com.cn/a/202305/06/WS6455206ca310b6054fad1547.html. Updated 2023-05-06. Accessed 2023-07-21.

[8] Müller-Wieland D, Marx N, Dreher M, Fritzen K, Schnell O. COVID-19 and Cardiovascular Comorbidities. Exp Clin Endocrinol Diabetes. 2022;130(3):178-189.

[9] Shahid Z, Kalayanamitra R, McClafferty B, et al. COVID-19 and Older Adults: What We Know. J Am Geriatr Soc. 2020;68(5):926-929.

[10] Crowley SD, Rudemiller NP. Immunologic Effects of the Renin-Angiotensin System. J Am Soc Nephrol. 2017;28(5):1350-1361.

[11] Ran J, Song Y, Zhuang Z, et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res. 2020;43(11):1267-1276.

[12] Burnier M, Polychronopoulou E, Wuerzner G. Hypertension and Drug Adherence in the Elderly. Front Cardiovasc Med. 2020;7:49.

[13] Kang CD, Tsang PP, Li WT, et al. Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: a cross-sectional study. Int J Cardiol. 2015;182:250-257.

[14] Rolnick SJ, Pawloski PA, Hedblom BD, Asche SE, Bruzek RJ. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2):54-65.

[15] Alcántara C, Edmondson D, Moise N, Oyola D, Hiti D, Kronish IM. Anxiety sensitivity and medication nonadherence in patients with uncontrolled hypertension. J Psychosom Res. 2014;77(4):283-286.

[16] Kretchy IA, Owusu-Daaku FT, Danquah SA. Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence. Int J Ment Health Syst. 2014;8:25.

[17] Organization WH. Guideline for the pharmacological treatment of hypertension in adults. https://www.who.int/publications/i/item/9789240033986. Accessed 2023-07-24.

[18] Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.

[19] Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(4):e5641.

[20] Marcum ZA, Zheng Y, Perera S, et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Social Adm Pharm. 2013;9(6):817-827.

[21] Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S. Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence. Vasc Health Risk Manag. 2016;12:407-413.

[22] Said B, Gharawi MO, Dallak FH, et al. Factors Associated with Anxiety During COVID-19 Pandemic and Its Association with Hypertension in Saudi Arabia. Patient Prefer Adherence. 2023;17:905-912.

[23] Liu Y, Li P, Lv Y, et al. Public awareness and anxiety during COVID-19 epidemic in China: A cross-sectional study. Compr Psychiatry. 2021;107:152235.

[24] Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615.

[25] Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020;383(20):1920-1931.

[26] Wang G, Yao Y, Wang Y, et al. Determinants of COVID-19 vaccination status and hesitancy among older adults in China. Nat Med. 2023;29(3):623-631.

[27] Zota D, Diamantis DV, Katsas K, et al. Essential Skills for Health Communication, Barriers, Facilitators and the Need for Training: Perceptions of Healthcare Professionals from Seven European Countries. Healthcare (Basel). 2023;11(14).

[28] Fiscella K, Meldrum S, Franks P, et al. Patient trust: is it related to patient-centered behavior of primary care physicians? Med Care. 2004;42(11):1049-1055.

[29] Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826-834.

[30] Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers. European Society of Cardiology. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang. Accessed [2023-05-23].

[31] A statement from the International Society of Hypertension on COVID-19. International Society of Hypertension. https://ish-world.com/a-statement-from-the-international-society-of-hypertension-on-covid-19/. Updated 2020-03-16. Accessed 2023-05-23.

[32] Lawler PR, Derde LPG, van de Veerdonk FL, et al. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. Jama. 2023;329(14):1183-1196.